Aaron T Beck1, Robyn Himelstein1, Keith Bredemeier2, Steven M Silverstein3, Paul Grant1. 1. Department of Psychiatry,University of Pennsylvania,Philadelphia,Pennsylvania,USA. 2. Center for Assessment Research and Translation,University of Delaware,Newark,Delaware,USA. 3. Department of Psychiatry,Rutgers - Robert Wood Johnson Medical School,Piscataway Township,New Jersey,USA.
Abstract
BACKGROUND: Neurocognitive deficits are often seen as core features of schizophrenia, and as primary determinants of poor functioning. Yet, our clinical observations suggest that individuals who score within the impaired range on standardized tests can reliably perform better in complex real-world situations, especially when performance is embedded within a positive socio-affective context. METHODS: We analyzed literature on the influence of non-neurocognitive factors on test performance in order to clarify their contributions. RESULTS: We identified seven non-neurocognitive factors that significantly contribute to neurocognitive test performance: avolition, dysfunctional attitudes, effort, stress, negative emotions, asociality, and disorganized symptoms. We then proposed an alternative model based on dysfunctional (e.g. defeatist) attitudes and their consequences for motivation and sustained task engagement. We demonstrated that these factors account for substantial variance in negative symptoms, neurocognitive test performance, and functional outcomes. We then demonstrated that recovery-oriented cognitive therapy - which is derived from this alternative model and primarily targets dysfunctional beliefs - has been successful in the treatment of low functioning individuals with schizophrenia. CONCLUSION: The contributions of neurocognitive impairments to poor real-world functioning in people with schizophrenia may be overstated in the literature, and may even be limited relative to non-neurocognitive factors. We offer suggestions for further research to more precisely quantify the contributions of attitudinal/motivation v. neurocognitive factors in schizophrenia.
BACKGROUND:Neurocognitive deficits are often seen as core features of schizophrenia, and as primary determinants of poor functioning. Yet, our clinical observations suggest that individuals who score within the impaired range on standardized tests can reliably perform better in complex real-world situations, especially when performance is embedded within a positive socio-affective context. METHODS: We analyzed literature on the influence of non-neurocognitive factors on test performance in order to clarify their contributions. RESULTS: We identified seven non-neurocognitive factors that significantly contribute to neurocognitive test performance: avolition, dysfunctional attitudes, effort, stress, negative emotions, asociality, and disorganized symptoms. We then proposed an alternative model based on dysfunctional (e.g. defeatist) attitudes and their consequences for motivation and sustained task engagement. We demonstrated that these factors account for substantial variance in negative symptoms, neurocognitive test performance, and functional outcomes. We then demonstrated that recovery-oriented cognitive therapy - which is derived from this alternative model and primarily targets dysfunctional beliefs - has been successful in the treatment of low functioning individuals with schizophrenia. CONCLUSION: The contributions of neurocognitive impairments to poor real-world functioning in people with schizophrenia may be overstated in the literature, and may even be limited relative to non-neurocognitive factors. We offer suggestions for further research to more precisely quantify the contributions of attitudinal/motivation v. neurocognitive factors in schizophrenia.
Authors: Philip T Yanos; Paul H Lysaker; Steven M Silverstein; Beth Vayshenker; Lauren Gonzales; Michelle L West; David Roe Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2019-04-01 Impact factor: 4.328
Authors: Sean A P Clouston; Katherine Jonas; Laura J Fochtmann; Evelyn J Bromet; Roman Kotov Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-18 Impact factor: 6.053
Authors: César González-Blanch; Leonardo A Medrano; Sarah Bendall; Simon D'Alfonso; Daniela Cagliarini; Carla McEnery; Shaunagh O'Sullivan; Lee Valentine; John F Gleeson; Mario Alvarez-Jimenez Journal: Eur Psychiatry Date: 2020-10-09 Impact factor: 5.361
Authors: Atiqul Haq Mazumder; Jennifer Barnett; Nina Lindberg; Minna Torniainen-Holm; Markku Lähteenvuo; Kaisla Lahdensuo; Martta Kerkelä; Jarmo Hietala; Erkki Tapio Isometsä; Olli Kampman; Tuula Kieseppä; Tuomas Jukuri; Katja Häkkinen; Erik Cederlöf; Willehard Haaki; Risto Kajanne; Asko Wegelius; Teemu Männynsalo; Jussi Niemi-Pynttäri; Kimmo Suokas; Jouko Lönnqvist; Solja Niemelä; Jari Tiihonen; Tiina Paunio; Aarno Palotie; Jaana Suvisaari; Juha Veijola Journal: Brain Sci Date: 2021-05-23
Authors: Javier Ortuño-Sierra; Rebeca Aritio-Solana; Eduardo Fonseca-Pedrero Journal: Int J Environ Res Public Health Date: 2020-03-13 Impact factor: 3.390